All stories
Jump to date
Friday, July 17 · 7 stories
- Industry
Commonwealth Fund Research Examines Private Equity Ownership in Four-State Hospital Analysis
The Commonwealth Fund is supporting new research analyzing private equity ownership patterns in hospitals and provider groups across four states. The research examines how private equity investments are affecting healthcare delivery organizations. The analysis provides state-level detail on ownership structures and operational changes. For Medicaid managed care organizations, private equity ownership of network providers can affect network stability, care continuity, service availability, and provider contracting dynamics.
- Industry
TrumpRx Discount Website Covers Limited Share of Brand-Name Drugs After Six Months
The TrumpRx administration-backed prescription drug discount website has been operational for nearly six months but covers only a fraction of brand-name medications. The platform's limited formulary raises questions about its practical utility for consumers seeking prescription cost relief. The scope of coverage and actual impact on out-of-pocket costs remains unclear. For Medicaid managed care organizations, this development is relevant only if it affects member cost-sharing, supplemental benefit design, or pharmacy network strategies.
- Industry
Insurers to Pay $759 Million in MLR Rebates for 2024 Performance
Health insurers will pay an estimated $759.2 million in Medical Loss Ratio rebates in 2026 based on 2024 performance, according to KFF analysis of preliminary data filed with state regulators. The rebates go to individuals and employers in fully-insured plans where insurers failed to meet minimum MLR thresholds—80% for individual and small group markets, 85% for large group plans. This year's rebate total is lower than most prior years. Payments typically reach consumers by September 30, 2026.
- Industry
Peterson Health Technology Institute Examines AI Deployment in Prior Authorization and Medical Billing
The Peterson Health Technology Institute is evaluating how providers and payers are deploying artificial intelligence in administrative functions including prior authorization, medical coding, and billing. Providers are using AI tools to optimize revenue capture and documentation, while insurers deploy similar technology for claims review and utilization management. PHTI's executive director Caroline Pearson notes the central question is whether these technologies reduce total healthcare spending or simply accelerate existing reimbursement disputes. The institute previously found that digital diabetes management tools did not lower overall cost of care.
Thursday, July 16 · 2 stories
- Industry
KFF Analysis Examines Why Drug Prices Dominate Policy Debate Over Hospital Costs
KFF's Larry Levitt published a JAMA Health Forum post identifying four reasons why high drug prices receive more policy attention than hospital prices, despite hospitals accounting for 40% of national health spending growth from 2022 to 2024. The analysis explores barriers to hospital price restraint and potential policy interventions. The post provides context for understanding the political economy of health care cost containment efforts. No immediate policy changes are announced.
- Industry
HCA Cuts 2026 Earnings Forecast After $400M Loss on ACA Coverage Drops
HCA Healthcare reduced its 2026 earnings forecast after losing $400 million in the second quarter due to payer mix changes, primarily from patients dropping Affordable Care Act marketplace coverage. The coverage losses exceeded both company and investor expectations. The development affects the second quarter of 2026, with the company announcing revised earnings guidance in July 2026. For Medicaid managed care organizations, this signals potential market instability and coverage churn that could affect member attribution, provider network partnerships, and redetermination processes if consumers losing marketplace coverage seek Medicaid eligibility.
Wednesday, July 15 · 5 stories
- Industry
Children's Hospitals Face 16 Active Pediatric Drug Shortages Including Six IV Products
Pediatric drugs represent the therapeutic category most affected by active drug shortages, with 16 ongoing shortages including six involving IV fluids and additives. Children's hospitals face unique challenges managing these shortages compared to adult health systems due to weight-based dosing, limited alternative formulations, and smaller patient volumes that reduce purchasing leverage. The article examines operational strategies pediatric hospitals use to manage supply disruptions, though specific policy interventions or effective dates are not detailed.
- Industry
720 Rural Hospitals at Risk of Closure as Surgical Access Gaps Widen
A Center for Healthcare Quality and Payment Reform report finds that roughly one-third of rural hospitals — 720 facilities — face closure risk, raising questions about surgical access in underserved areas. As rural hospitals retreat from operating room services, the analysis highlights growing surgical care deserts. The report does not specify a timeline for closures but underscores ongoing financial instability in rural provider markets. For Medicaid managed care organizations with rural network obligations, this trend signals potential network adequacy challenges and increased need for alternative surgical access strategies.
- Industry
Elevance Health Plans Further Medicaid Portfolio Exit Amid High Costs
Elevance Health, the nation's second-largest health insurer, announced plans to reduce its Medicaid managed care footprint over the next year as medical costs remain elevated. The exit comes as states prepare to implement Medicaid work requirements. Elevance operates Medicaid plans in multiple states under its Anthem and Wellpoint brands. The decision reflects ongoing profitability challenges in Medicaid managed care following the end of pandemic-era continuous enrollment provisions.
- Industry
FTC Settles with CVS Caremark Over Insulin Price Manipulation Claims
The Federal Trade Commission has settled a lawsuit against CVS Caremark over allegations the company artificially inflated insulin prices and restricted access to diabetes treatment. The settlement resolves FTC charges related to the pharmacy benefit manager's pricing practices for insulin products. The action follows broader federal scrutiny of PBM practices affecting drug pricing and access. Terms of the settlement were not disclosed in the initial report.
- Industry
CVS Caremark Settles FTC Insulin Suit, Must End Rebate-Driven Formulary Preferences
CVS Caremark reached a settlement with the Federal Trade Commission over insulin pricing practices. The terms mirror the FTC's earlier settlement with Express Scripts and prohibit the pharmacy benefit manager from favoring higher-cost drug versions on standard formularies based on rebate arrangements. The settlement takes effect immediately upon court approval. For Medicaid managed care plans that contract with CVS Caremark or operate integrated PBM arrangements, this settlement signals continued federal scrutiny of rebate-driven formulary design and may preview future enforcement against similar practices affecting Medicaid populations.
Tuesday, July 14 · 3 stories
- Industry
HHS Secretary Kennedy Advances Initiative to Reduce SSRI Antidepressant Use
U.S. Health and Human Services Secretary Robert F. Kennedy Jr. is moving forward with an initiative aimed at helping Americans discontinue selective serotonin reuptake inhibitor (SSRI) antidepressants. The effort represents a significant policy shift at the federal level regarding mental health treatment approaches. The initiative's specific implementation mechanisms, timeline, and scope remain unclear from available reporting. For Medicaid managed care organizations, any federal guidance or directives affecting prescription psychiatric medications could have major implications for behavioral health benefit design, formulary management, prior authorization protocols, and member continuity of care.
- Industry
HCA Reports Lower Profits as Uninsured Patient Volume Rises After ACA Subsidy Expiration
Hospital chain HCA Healthcare reported declining profits attributed to increased uninsured patient volume following the expiration of enhanced Affordable Care Act subsidies. The company cited rising uncompensated care costs as patients lost marketplace coverage. This represents an early signal of coverage losses affecting provider revenues after the federal government allowed pandemic-era ACA premium subsidies to lapse. The trend may accelerate Medicaid enrollment as individuals lose private coverage and income-qualify for state programs.
- Industry
AIDS Activists Obtain Biden-Gilead HIV Prevention Patent Settlement R&D Agreement
AIDS activists have obtained a research and development agreement that formed the basis of a settlement between the Biden administration and Gilead Sciences concerning patents for HIV prevention drugs. The activists are criticizing the terms of the settlement deal. The agreement relates to pre-exposure prophylaxis (PrEP) medications used to prevent HIV transmission. This development follows years of dispute over whether the federal government held patent rights to Gilead's HIV prevention drugs and the terms under which those drugs should be made available.
Monday, July 13 · 2 stories
- Industry
House Passes Bipartisan Tax Credit Extension Bill
The U.S. House of Representatives approved a bipartisan bill extending tax credits on January 8, 2026. The Association for Community Affiliated Plans (ACAP) CEO Margaret A. Murray issued a statement following the vote. The bill now moves to the Senate for consideration. Specific details on which tax credits are extended and the duration of the extension were not provided in the available excerpt.
- Industry
Home Health Care News Profiles Six Home Care Companies for 2026
Home Health Care News published a profile of six home care companies navigating operational challenges in 2026. The article cites Medicaid reimbursement pressures, proposed 80-hour work requirements, fraud enforcement, technology adoption, and mergers and acquisitions as key factors shaping the sector. The publication does not report specific policy changes or enforcement actions, but rather frames the operating environment for home care providers. No effective dates or comment periods are provided because this is an industry profile rather than a policy document.
Friday, July 10 · 3 stories
- Industry
Sturgis Hospital Closes After 101 Years as 720 U.S. Hospitals Face Closure Risk
Sturgis Hospital in Michigan closed June 19, 2026, after 101 years of operation, following a 13% volume decrease over two years. An estimated 720 hospitals nationwide are at risk of closure. The closures disproportionately affect rural facilities facing declining patient volumes and financial pressures. For Medicaid managed care organizations, rural hospital closures threaten network adequacy, emergency access, and continuity of care for beneficiaries in underserved areas.
- Industry · IA
CommonSpirit Closes Labor and Delivery Services at Iowa Hospital
CHI Health Mercy Council Bluffs will end labor and delivery and Level 2 NICU services on August 31, 2026. CommonSpirit Health will consolidate these services at its Omaha birth centers, located approximately 15 minutes away, which currently deliver over 4,460 babies annually. Patients will transition to the Omaha facilities for obstetric care.
- Industry
Dementia Costs Projected at $818 Billion in 2026, Threatening Home Health Workforce
Dementia and Alzheimer's disease are projected to cost the United States $818 billion in 2026, with families and individuals bearing more than 80% of the economic burden according to a study in Alzheimer's & Dementia. Flournoy Health Systems CEO warns this growing cost pressure could further strain the home health workforce. The projections come as managed care organizations face increasing demand for long-term services and supports, particularly home and community-based services for members with cognitive impairment. The workforce impact threatens network adequacy for LTSS benefits.
Thursday, July 9 · 3 stories
- Industry
ACA Marketplace Insurers Propose 14% Premium Increase for 2027
Insurers participating in ACA Marketplaces are proposing a median premium increase of 14% for 2027, based on preliminary rate filings analyzed in 16 states and DC. This follows steep increases in 2026, bringing total premium growth to over one-third between 2025 and 2027. The analysis reflects preliminary filings subject to final regulatory review. Final rates will be determined later in 2026 ahead of the 2027 plan year.